James M. Balkovec

4.4k total citations · 1 hit paper
47 papers, 2.9k citations indexed

About

James M. Balkovec is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, James M. Balkovec has authored 47 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in James M. Balkovec's work include Antifungal resistance and susceptibility (11 papers), Hormonal Regulation and Hypertension (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). James M. Balkovec is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Hormonal Regulation and Hypertension (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). James M. Balkovec collaborates with scholars based in United States. James M. Balkovec's co-authors include Barry M. Trost, George K. Abruzzo, James F. Dropinski, Ken Bartizal, G. S. PONTICELLO, Sándor Varga, Stephen A. Godleski, James P. Springer, John L. Belletire and Patrick G. McDougal and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

James M. Balkovec

46 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

On the use of the O-methylmandelate ester for establishment of absolute configuration of secondary alcohols

1986 536 citations James M. Balkovec et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
James M. Balkovec	1.0k	939	753	744	592	47	2.9k
Larissa M. Podust	555 0.5×	958 1.0×	2.2k 2.9×	685 0.9×	886 1.5×	76	4.2k
Roberto Di Santo	1.1k 1.1×	1.8k 1.9×	1.4k 1.8×	366 0.5×	398 0.7×	162	3.9k
David C. Lamb	1.6k 1.5×	467 0.5×	2.5k 3.3×	1.1k 1.5×	1.4k 2.4×	120	5.4k
Yongbing Cao	1.2k 1.2×	785 0.8×	1.2k 1.6×	767 1.0×	327 0.6×	135	3.5k
Kelly Chibale	671 0.6×	2.1k 2.3×	1.3k 1.8×	470 0.6×	343 0.6×	166	4.3k
Roberta Costi	867 0.8×	1.4k 1.5×	1.2k 1.5×	292 0.4×	322 0.5×	139	3.2k
Craig J. Canfield	545 0.5×	625 0.7×	956 1.3×	496 0.7×	391 0.7×	56	4.3k
Milton L. Hammond	262 0.3×	1.1k 1.1×	666 0.9×	212 0.3×	499 0.8×	73	2.3k
Inshad Ali Khan	698 0.7×	789 0.8×	1.4k 1.8×	292 0.4×	519 0.9×	97	3.1k
Po‐Huang Liang	1.8k 1.7×	817 0.9×	3.7k 5.0×	289 0.4×	844 1.4×	135	6.7k

Countries citing papers authored by James M. Balkovec

Since Specialization

Citations

This map shows the geographic impact of James M. Balkovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Balkovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Balkovec more than expected).

Fields of papers citing papers by James M. Balkovec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Balkovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Balkovec. The network helps show where James M. Balkovec may publish in the future.

Co-authorship network of co-authors of James M. Balkovec

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Balkovec. A scholar is included among the top collaborators of James M. Balkovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Balkovec. James M. Balkovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Annie, Mingming Wang, Padmaja Paderu, et al.. (2024). CTC-177, a novel drug–Fc conjugate, shows promise as an immunoprophylactic agent against multidrug-resistant Gram-negative bacterial infections. JAC-Antimicrobial Resistance. 6(4). dlae100–dlae100.

Balkovec, James M., David L. Hughes, Prakash Masurekar, et al.. (2013). Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study. Natural Product Reports. 31(1). 15–34. 122 indexed citations

Heasley, Brian, Gregory J. Pacofsky, Ahmed Mamai, et al.. (2012). Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthase. Bioorganic & Medicinal Chemistry Letters. 22(22). 6811–6816. 28 indexed citations

Sun, Wanying, Milana Maletic, Steven S. Mundt, et al.. (2011). Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1. Bioorganic & Medicinal Chemistry Letters. 21(7). 2141–2145. 11 indexed citations

Maletic, Milana, Michael J. Szymonifka, Steven S. Mundt, et al.. (2011). Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters. 21(8). 2568–2572. 12 indexed citations

Aster, Susan D., Donald W. Graham, Gool F. Patel, et al.. (2008). Bis-aryl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Bioorganic & Medicinal Chemistry Letters. 18(9). 2799–2804. 38 indexed citations

Olson, Steven H., Donald W. Graham, Gool F. Patel, et al.. (2008). Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 18(11). 3412–3416. 38 indexed citations

Olson, Steven H., Anne Hermanowski‐Vosatka, Steven S. Mundt, et al.. (2008). 4-Methyl-5-phenyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 18(11). 3405–3411. 22 indexed citations

Olson, Steven H., James M. Balkovec, Yunping Zhu, et al.. (2006). Attenuating pregnane X receptor (PXR) activation: A molecular modelling approach. Xenobiotica. 37(2). 124–138. 51 indexed citations

10.

Gu, Xin, Jasminka Dragovic, Gloria C. Koo, et al.. (2005). Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters. 15(23). 5266–5269. 40 indexed citations

11.

Olson, Steven H., Susan D. Aster, Kai Brown, et al.. (2005). Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Bioorganic & Medicinal Chemistry Letters. 15(19). 4359–4362. 76 indexed citations

12.

Thieringer, Rolf, James M. Balkovec, Steven S. Mundt, et al.. (2004). A novel non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of metabolic syndrome in murine disease models. 7. 6 indexed citations

13.

Toney, Jeffrey H., Gail G. Hammond, Paula M.D. Fitzgerald, et al.. (2001). Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase. Journal of Biological Chemistry. 276(34). 31913–31918. 171 indexed citations

14.

Hammond, Gail G., Joann Huber, Mark L. Greenlee, et al.. (1999). Inhibition of IMP-1 metallo-Î²-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiology Letters. 179(2). 289–296. 42 indexed citations

15.

Greenlee, Mark L., et al.. (1999). Synthesis and SAR of thioester and thiol inhibitors of IMP-1 Metallo-β-Lactamase. Bioorganic & Medicinal Chemistry Letters. 9(17). 2549–2554. 49 indexed citations

16.

Justice, Michael, et al.. (1998). Elongation Factor 2 as a Novel Target for Selective Inhibition of Fungal Protein Synthesis. Journal of Biological Chemistry. 273(6). 3148–3151. 148 indexed citations

17.

Balkovec, James M., et al.. (1998). Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast. Bioorganic & Medicinal Chemistry Letters. 8(16). 2269–2272. 24 indexed citations

18.

Bouffard, F. Aileen, Robert A. Zambias, James F. Dropinski, et al.. (1994). Synthesis and Antifungal Activity of Novel Cationic Pneumocandin Bo Derivatives. Journal of Medicinal Chemistry. 37(2). 222–225. 94 indexed citations

19.

Balkovec, James M., Regina M. Black, Milton L. Hammond, et al.. (1992). Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP). Journal of Medicinal Chemistry. 35(1). 194–198. 55 indexed citations

20.

Schmatz, Dennis M., George K. Abruzzo, Maryann Powles, et al.. (1992). Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.. The Journal of Antibiotics. 45(12). 1886–1891. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact